BIAL is an innovative international pharmaceutical company with products available in more than 50 countries. Founded in 1924, BIAL’s mission is to discover, develop and provide therapeutic solutions within the area of human health. In recent decades, the company has strategically focused on quality, innovation and internationalisation. BIAL consistently channelled more than 20% of its annual turnover into research and development within neurosciences and the cardiovascular system.
In 2009, BIAL launched eslicarbazepine acetate in Europe and later launched in the USA in 2014 in partnership with Sunovion. The drug was co-marketed in Europe with Eisai until February 2021.
At the end of 2016, BIAL launched and commercialised opicapone in Europe. In September 2021, BIAL received exclusive rights from Sunovion to commercialise apomorphine sublingual film in Europe.
The company headquarters are in Portugal. BIAL also has affiliates in Spain, Germany, the UK, Italy, Switzerland, and in emergent markets such as Angola, Mozambique, Panama and Ivory Coast. In the USA, BIAL has established BIAL Biotech Investments Inc. (BIAL Biotech), a research centre located in the heart of the Boston biotech cluster, for the development of genetically-defined Parkinson’s disease therapeutics.
BIAL expects to strengthen its international presence by continuing to deliver innovative medicines to healthcare professionals, patients and their families, always inspired by its motivation: “Keeping life in mind”.
Keep ON learning
Harnessing the power of knowledge sharing.
Building a brighter future for people with Parkinson’s
So, what is Keep ON learning?
An online experience with continually evolving CPD accredited learning programmes from top international and national experts on subjects ranging from clinical practice to high-level research in Parkinson’s for health professionals.
Want access? Register HERE!--
Keep it ON
Keep it ON is a community created by Bial Pharmaceuticals with the mission of empowering people with Parkinson’s. We want to create relevant and useful content for PwP and their caregivers, to help keep their lives ON and to generate awareness regarding the complexity of Parkinson’s.
Click HERE to visit
This promotional stand is organised and funded by BIAL.
Click here for Prescribing Information.
Adverse events should be reported. For UK healthcare professionals: reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should be also reported to Bial on +44 (0) 1628 531171 or email@example.com
UK/ON/2021/051 Date of preparation: October 2021